Booster Dose of COVID-19 Vaccine for Kidney Transplant Recipients Without Adequate Humoral Response
Phase 4
- Conditions
- ImmunosuppressionCOVID-19 Acute Respiratory Distress Syndrome
- Interventions
- Biological: The Pfizer mRNA-based BNT162b2 vaccine
- First Posted Date
- 2021-07-14
- Last Posted Date
- 2021-10-08
- Lead Sponsor
- dafna yahav
- Target Recruit Count
- 504
- Registration Number
- NCT04961229
© Copyright 2025. All Rights Reserved by MedPath